+Compare
VYNE
Stock ticker:
NASDAQ
AS OF
Aug 5 closing price
Price
$0.42
Change
+$0.01 (+2.44%)
Capitalization
24.07M

VYNE VYNE Therapeutics Forecast, Technical & Fundamental Analysis

a company, which engages in development and commercialization of serlopitant products
Industry Biotechnology
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 05, 2022

Momentum Indicator for VYNE turns negative, indicating new downward trend

VYNE saw its Momentum Indicator move below the 0 level on July 22, 2022. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned negative. In 66 of the 73 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VYNE turned negative on July 26, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

VYNE moved below its 50-day moving average on July 29, 2022 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VYNE crossed bearishly below the 50-day moving average on August 02, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYNE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VYNE advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

VYNE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.432) is normal, around the industry mean (26.217). P/E Ratio (2.709) is within average values for comparable stocks, (100.146). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.703). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.499) is also within normal values, averaging (316.522).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VYNE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYNE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

AI

View a ticker or compare two or three

VYNE
Buy/Sell Ratings
 
 
Technical Analysis# Of IndicatorsAvg. Odds
   
   
 
AI
A.I. Advisor
published Earnings

VYNE is expected to report earnings to fall 272.50% to -17 cents per share on August 11

VYNE Therapeutics VYNE Stock Earnings Reports
Q2'22
Est.
$-0.17
Q1'22
Beat
by $0.26
Q4'21
Beat
by $0.05
Q3'21
Missed
by $0.05
Q2'21
Est.
$-0.35
The last earnings report on May 12 showed earnings per share of 10 cents, beating the estimate of -15 cents. With 117.15K shares outstanding, the current market capitalization sits at 24.07M.
AI
A.I. Advisor
published General Information

General Information

a company, which engages in development and commercialization of serlopitant products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
520 U.S. Highway 22
Phone
+1 800 775-7936
Employees
28
Web
https://www.vynetherapeutics.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABR15.640.02
+0.13%
Arbor Realty Trust
TRGP63.72-0.22
-0.34%
Targa Resources Corp
RGCO20.25-0.17
-0.83%
RGC Resources
AMRK32.85-0.64
-1.91%
A-Mark Precious Metals
BRQS1.23-0.04
-3.15%
Borqs Technologies

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with BTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then BTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
+0.75%
BTX - VYNE
41%
Loosely correlated
+1.60%
CLBS - VYNE
38%
Loosely correlated
-1.94%
XFOR - VYNE
37%
Loosely correlated
-5.51%
SEEL - VYNE
37%
Loosely correlated
+2.84%
KMPH - VYNE
36%
Loosely correlated
+4.72%
More